Enterprise Financial Services Corp (EFSC)’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-525
Closed -$85K 408
2021
Q3
$85K Hold
525
0.01% 308
2021
Q2
$86K Hold
525
0.01% 302
2021
Q1
$79K Hold
525
0.01% 323
2020
Q4
$80K Sell
525
-140
-21% -$20K 0.02% 308
2020
Q3
$90K Buy
665
+140
+27% +$19K 0.02% 297
2020
Q2
$72K Hold
525
0.02% 324
2020
Q1
$57K Hold
525
0.01% 333
2019
Q4
$63K Hold
525
0.01% 376
2019
Q3
$52K Hold
525
0.01% 387
2019
Q2
$57K Hold
525
0.01% 388
2019
Q1
$59K Buy
+525
New +$57.6K 0.01% 377

Other funds holding IBB

Enterprise Financial Services Corp (EFSC)'s IBB Position: Q4 2021 in Review

Enterprise Financial Services Corp (EFSC) sold out of iShares Biotechnology ETF (IBB) in Q4 2021, closing a stake of 525 shares — an estimated $85K sold.

Enterprise Financial Services Corp (EFSC) first reported a position in IBB in Q1 2019 and held it in 11 quarters. The position peaked at $90K in Q3 2020. 962 funds tracked by Wall St. Rank hold IBB as of Q4 2021.

  • Enterprise Financial Services Corp (EFSC) reported no remaining iShares Biotechnology ETF position as of Q4 2021 after selling out during the quarter.
  • Enterprise Financial Services Corp (EFSC) sold 525 iShares Biotechnology ETF shares in Q4 2021, an estimated $85K.
  • Enterprise Financial Services Corp (EFSC) first reported a position in iShares Biotechnology ETF in Q1 2019 and held it in 11 quarters.
  • Enterprise Financial Services Corp (EFSC)'s iShares Biotechnology ETF position peaked at $90K in Q3 2020.
  • 962 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2021.

Based on Enterprise Financial Services Corp (EFSC)'s 13F filing for Q4 2021, filed 14 Feb 2022.